Nanoengineered Stent Surface to Reduce In-Stent Restenosis in Vivo

Volume: 9, Issue: 23, Pages: 19677 - 19686
Published: Jun 2, 2017
Abstract
In-stent restenosis (ISR) is the leading cause of stent failure and is a direct result of a dysfunctional vascular endothelium and subsequent overgrowth of vascular smooth muscle tissue. TiO2 nanotubular (NT) arrays have been shown to affect vascular endothelial cells (VECs) and vascular smooth muscle cells (VSMCs) in vitro by accelerating VEC cell proliferation and migration while suppressing VSMCs. This study investigates for the first time...
Paper Details
Title
Nanoengineered Stent Surface to Reduce In-Stent Restenosis in Vivo
Published Date
Jun 2, 2017
Volume
9
Issue
23
Pages
19677 - 19686
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.